WEILL CORNELL MEDICINE and New York Genome Center will receive a NCI grant worth $490,000 annually for five years to support a joint cancer genomics data center for the research and clinical interpretation of tumors. The WCM-NYGC center will perform computational analyses examining DNA and RNA to understand the role of different mutations and to...
In this episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, Jacquelyn Cobb, managing editor, discuss the Sept. 23 meeting of the FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee, during which the panel voted in favor of Galleri, the multi-cancer detection test from GRAIL Inc., to become the first multi-cancer detection test to receive regulatory approval.
